Eaton Vance Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,600
Closed -$148K 2685
2021
Q4
$148K Hold
3,600
﹤0.01% 1673
2021
Q3
$0 Sell
3,600
-27
-0.7% -$1.18K ﹤0.01% 2698
2021
Q2
$145K Buy
3,627
+2,081
+135% +$89K ﹤0.01% 1742
2021
Q1
$83K Buy
+1,546
New +$89K ﹤0.01% 1650

Other funds holding VCYT

Eaton Vance Management's VCYT Position: Q1 2022 in Review

Eaton Vance Management sold out of Veracyte (VCYT) in Q1 2022, closing a stake of 3,600 shares — an estimated $148K sold.

Eaton Vance Management first reported a position in VCYT in Q1 2021 and held it in 4 quarters. The position peaked at $148K in Q4 2021. 205 funds tracked by Wall St. Rank hold VCYT as of Q1 2022.

  • Eaton Vance Management reported no remaining Veracyte position as of Q1 2022 after selling out during the quarter.
  • Eaton Vance Management sold 3,600 Veracyte shares in Q1 2022, an estimated $148K.
  • Eaton Vance Management first reported a position in Veracyte in Q1 2021 and held it in 4 quarters.
  • Eaton Vance Management's Veracyte position peaked at $148K in Q4 2021.
  • 205 funds tracked by Wall St. Rank held Veracyte as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.